Friday, February 27, 2009

Ranbaxy runs into problems with the FDA

Ranbaxy, and Indian drug manufacturer, has been accused by the FDA for falsifying data. They're halting the review of all applications from the Paonta Sahib Manufacturing plant. Among other things, they're accused of failing to test the shelf life of the drugs and lying about the results.

For more information, read the article at the Wall Street Heatlh Journal here.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment